Department of Medicine, Beth Israel Hospital, 330 Brookline Avenue, Boston, MA 02215, USA

This email address is being protected from spam bots, you need Javascript enabled to view it

Metabolic syndrome is characterized by insulin insensitivity, central obesity dyslipidemia, and hypertension. It is recognized as a risk factor for cardiovascular disease in men; by the time metabolic syndrome is diagnosed, however, most men already have entrenched cardiovascular disease. A reliable early warning sign is needed to alert physicians to those at risk for metabolic syndrome and cardiovascular disease. Low serum testosterone level has emerged as a reliable prognosticator of metabolic syndrome in men whose testosterone deficiency is genetic (Klinefelter syndrome), iatrogenic following surgery for testicular cancer, pharmacologically induced by gonadotropin-releasing hormone during prostate cancer treatment, or a natural consequence of aging. One third of men with type 2 diabetes mellitus are now recognized as testosterone deficient. Emerging evidence suggests that testosterone therapy may be able to reverse some aspects of metabolic syndrome.

Written by
Spark RF.

Reference
Curr Urol Rep. 2007 Nov;8(6):467-71

PubMed Abstract
PMID:18042326

UroToday.com Androgen Deficiency Section

Please log-in or register in order to submit comments.

Powered by AkoComment!